非透析依赖慢性肾病患者CLTI:旁路移植与腔内治疗对比
CRITISCH注册研究分析337例非透析依赖CKD合并CLTI患者,比较旁路移植(BG)与腔内治疗(EVT)。Cox回归显示BG与更差的截肢-free生存相关(HR 1.78,95%CI 1.05-3.03,p=0.028),男性、既往心梗及无流出道血管是预后不良预测因素。
要点
- 非透析依赖CKD合并CLTI患者中,BG较EVT截肢或死亡风险显著增加(HR 1.78)。
- 无流出道血管与更差的无截肢生存(HR 1.73)及死亡风险(HR 1.76)相关。
- 男性及既往心肌梗死与更高的截肢风险相关(HR分别为2.21和3.74)。
核心结论
- 在非透析依赖CKD合并CLTI患者中,旁路移植与较差的截肢-free生存相关,而腔内治疗可能更优。
研究设计与样本
- CRITISCH注册研究为前瞻性、全国性、多学科、多中心注册,连续纳入1200例CLTI患者。
- 本分析仅纳入337例非透析依赖CKD患者,其中旁路移植组86例(中位年龄78岁,48例男性),腔内治疗组251例(中位年龄80岁,135例男性)。
主要发现
- 旁路移植组截肢或死亡风险显著高于腔内治疗组(HR 1.78,95%CI 1.05-3.03,p=0.028)。
- 无截肢生存时间(AFT)和总生存(OS)在旁路移植组风险数值更高但差异无统计学意义(AFT:HR 1.66,95%CI 0.78-3.53,p=0.188;OS:HR 1.41,95%CI 0.80-2.47,p=0.348)。
- 无流出道血管与更差的AFS相关(HR 1.73,95%CI 1.15-2.60,p=0.008)。
- 男性(HR 2.21,95%CI 1.10-4.45,p=0.027)和心肌梗死(HR 3.74,95%CI 1.23-11.35,p=0.020)与更高的截肢风险相关。
- 无流出道血管(HR 1.76,95%CI 1.11-2.80,p=0.016)和更高风险评分(HR 1.73,95%CI 1.03-2.91,p=0.038)与死亡风险增加相关。
临床怎么用
- 对于非透析依赖CKD合并CLTI患者,选择血运重建方式时需权衡旁路移植与腔内治疗的获益风险。
- 应评估流出道血管情况、性别及心肌梗死病史等预后因素以指导治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose: To report the outcomes of bypass grafting (BG) vs endovascular therapy (EVT) in patients with non-dialysis-dependent chronic kidney disease (CKD) and chronic limb-threatening ischemia (CLTI). Materials and Methods: The CRITISCH Registry is a prospective, national, interdisciplinary, multicenter registry evaluating the current practice of all available treatment options in 1200 consecutive CLTI patients. For the purposes of this analysis, only the 337 patients with non-dialysis-dependent CKD treated by either BG (n=86; median 78 years, 48 men) or EVT (n=251; median age 80 years, 135 men) were analyzed. The primary composite outcome was amputation-free survival (AFS); secondary outcomes were overall survival (OS) and amputation-free time (AFT). All outcomes were evaluated in Cox proportional hazards models; the results are reported as the hazard ratio (HR) and 95% confidence interval (CI). Results: The Cox regression analysis revealed a significantly greater hazard of amputation or death after BG (HR 1.78, 95% CI 1.05 to 3.03, p=0.028). The models for AFT and overall survival also suggested a higher hazard for BG, but the differences were not significant (AFT: HR 1.66, 95% CI 0.78 to 3.53, p=0.188; OS: HR 1.41, 95% CI 0.80 to 2.47, p=0.348). The absence of runoff vessels (HR 1.73, 95% CI 1.15 to 2.60, p=0.008) was associated with a decreased AFS. The likelihood of amputation was higher in male patients (HR 2.21, 95% CI 1.10 to 4.45, p=0.027) and was associated with a lack of runoff vessels (HR 1.95, 95% CI 0.96 to 3.95, p=0.065) and myocardial infarction (HR 3.74, 95% CI 1.23 to 11.35, p=0.020). Death was more likely in patients without runoff vessels (HR 1.76, 95% CI 1.11 to 2.80, p=0.016) and those with a higher risk score (HR 1.73, 95% CI 1.03 to 2.91, p=0.038). Conclusion: This analysis suggested that BG was associated with poorer AFS than EVT in patients with non-dialysis-dependent CKD and CLTI. Male sex, previous myocardial infarction, and the absence of runoff vessels were additionally identified as predictors of poorer outcomes.
引用
- Stavroulakis K, Gkremoutis A, Borowski M, et al. Bypass Grafting vs Endovascular Therapy in Patients With Non-Dialysis-Dependent Chronic Kidney Disease and Chronic Limb-Threatening Ischemia (CRITISCH Registry). J Endovasc Ther. 2020. PMID: 32633651. doi:10.1177/1526602820938465
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。